Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 110.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 148.50
  • 52 Week Low: 101.00
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 56,952
  • Market Cap: £116.85m
  • RiskGrade: 258

Wednesday broker round-up UPDATE

Date: Wednesday 17 Apr 2013

LONDON (ShareCast) - African Barrick Gold: Deutsche Bank cuts target price from 230p to 173p, while its hold recommendation is reiterated.

Ashmore Group: Morgan Stanley raises target price from 395p to 444p and maintains an equal-weight rating.

Ashtead Group: Jefferies increases target price from 615p to 690o and reiterates a buy recommendation.

Aquarius Platinum: Investec starts with a target price of 45p and a hold recommendation.

British American Tabacco: Nomura lowers target price from 4087p to 4012p, while its buy recommendation remains unchanged.

Cello Group: Sanlam Securities initiates with a target price of 75p and a buy recommendation.

Derwent London: Investec raises target price from 2275p to 2360p and maintains an add rating.

Escher Group Holdings: Panmure Gordon takes target price from 410p to 456p and reiterates a buy recommendation.

Falkland Islands Hodlings: WH Ireland cuts target price from 480p to 448p retaining a buy recommendation.

Fresnillo: Deutsche Bank takes tatget price from 1260p to 1040p and still recommends selling.

Fusion IP: HB Markets initiates with a speculative buy.

Hargreaves Lansdown: Jefferies increases target price from 1000p to 1150p, while maintaining a buy recommendation.

Hays: HSBC Holdings ups target price from 80p to 106p and leaves its neutral rating unaltered.

Hikma Pharmaceuticals: Jefferies reduces target price from 1150p to 1040p keeping a buy recommendation. Panmure Gordon cuts target price from 1100p to 1000p, while its buy recommendation remains unchanged.

Imperial Tabacco: Nomura cuts target price from 2443p to 2386p and reiterates a reduce rating.

Interbulk Group: Westhouse Securities shifts target price from 11p to 10p and keeps a buy recommendation.

InterContinental Hotels Group: Barclays downgrades to equal-weight with a target price of 2085p.

JD Sports Fashion: Investec increases target price from 830p to 860p staying with its buy recommendation.

Legal & General Group: Investec raises target price from 153p to 193p keeping a hold recommendation.

Man Group: Canaccord Genuity raises target price to 120p and upgrades from hold to buy.

Michael Page: Jefferies cuts target price from 520p to 500p and retains a buy recommendation. JP Morgan reduces target price from 389p to 370p maintaining a neutral rating. Citigroup lowers target price from 440p to 400p, while leaving its neutral rating unchanged. Credit Suisse moves target price from 400p to 360p and stays with an underperform rating. HSBC Holdings takes target price from 450p to 414p and downgrades to neutral.

Moneysupermarket.com: Westhouse Securities moves target price from 195p to 210p and upgrades from neutral to add.

Randgold Resources: Deutsche Bank cuts target price from 6030p to 5500p, while maintaining a buy recommendation.

Rio Tinto: Deutsche Bank reduces target price from 4521p to 4489p keeping a buy recommendation.

Sepura: Investec shifts target price from113p to 115p and leaves its buy recommendation unchanged.

Smiths News: N+1 Singer moves target price from 164p to 185p, but downgrades to hold.

Speedy Hire: Panmure Gordon shifts target price from 56p to 60p maintaining a buy recommendation.

Vodafone Group: Deutsche Bank shifts target price from 173p to 180p and maintains a hold recommendation. HSBC Holdings ups target price from 205p to 230p reiterating an overweight rating.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 110.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 148.50
52 Week Low 101.00
Volume 56,952
Shares Issued 106.23m
Market Cap £116.85m
RiskGrade 258

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
64.69% below the market average64.69% below the market average64.69% below the market average64.69% below the market average64.69% below the market average
83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average
Price Trend
21.22% above the market average21.22% above the market average21.22% above the market average21.22% above the market average21.22% above the market average
12.2% below the sector average12.2% below the sector average12.2% below the sector average12.2% below the sector average12.2% below the sector average
Income
26.26% below the market average26.26% below the market average26.26% below the market average26.26% below the market average26.26% below the market average
86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average
Growth
39.24% below the market average39.24% below the market average39.24% below the market average39.24% below the market average39.24% below the market average
38.89% below the sector average38.89% below the sector average38.89% below the sector average38.89% below the sector average38.89% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 09-Apr-2020

Time Volume / Share Price
16:31 25,000 @ 110.00p
16:06 25,000 @ 110.00p
15:57 608 @ 111.64p
15:45 1,897 @ 112.00p
14:39 4,450 @ 109.06p

Cello Health Key Personnel

CEO Mark Scott

Top of Page